\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes Digital, Industry & Space SemiconductorsThe Chips Joint Undertaking has opened a new call for proposal for a Design Platform (DIGITAL-Chips-2024-CSA-CDP-1).
This call concerns the selection of the consortium in charge of the overall coordination of the Design Platform, referred to as the Platform Coordination Team (PCT), which shall serve as the hosting entity for the Design Platform’s virtual infrastructure and central services, coordinating access to a wide range of tools, assets and services.
The chosen implementation model foresees a central consortium, referred to as the Platform Coordination Team (PCT) that operates the overall Design Platform initiative, serves as the hosting entity of the central cloud infrastructure and manages the development of its users. The PCT shall assist the Chips Joint Undertaking (Chips JU) in defining the technical specifications of the cloud service for the platform to be procured by the Chips JU through a dedicated Call for Tenders.
This call is interlinked with call DIGITAL-Chips-2024-CfEoI -CDP-1, a Call for Expression of Interest (hereinafter “CfEoI”) for the selection of a Hosting Consortium, see the Chips JU website for more information.
Only proposals successful in both interrelated calls will be considered for funding.
More information on the call can be found on the Funding & Tenders Portal. The deadline to submit proposals is 10 October 2024.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital Europe AI Continent Advanced Digital Skills Deployment: Best use of technologies
The European Commission has recently published the first amendment to the Digital Europe Main Work Programme 2025-2027, taking into account the most recent political priorities of the Commission. Among the main changes, the programme will now contribute to the landmark AI Gigafactories initiative, set to accelerate the development of cutting... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
